Humana Names Vice President and Medical Officer for Florida Commercial Markets

Humana Names Vice President and Medical Officer for Florida Commercial Markets

Humana Corporate CommunicationsNancy A. Hanewinckel, 941-585-4763

(NYSE: HUM), one of Florida’s leading health benefits companies, has named Dr. John Montgomery as its new vice president and medical officer for its Florida commercial markets.

In his new statewide role, Dr. Montgomery is responsible for leading Humana’s clinical programs for its commercial lines of business throughout the state. He will be based in Jacksonville.

Dr. Montgomery has been with Humana since October 2010, serving as the company’s regional medical director for Florida, responsible for clinical policy and physician clinical review. Recently, Dr. Montgomery also began overseeing all of Humana’s Commercial Outpatient Clinical Physician Review medical directors around the country.

“Dr. Montgomery brings more than 25 years of experience in health care delivery to this role,” said Dan Feruck, Humana President of Florida Employer Group Operations. “Our commercial members also will benefit tremendously from his experience as an industry leader focused on engaging physicians, providers and members to improve the access, quality and cost of health care.”

Dr. Montgomery currently serves as a delegate to the Florida Medical Association and as an alternate delegate to the American Medical Association. He was just nominated chair-elect of the board for the American Cancer Society’s Florida division. Dr. Montgomery is also a past president of the Duval County Medical Society and past director of Volusia County Health Department.

He received a bachelor’s degree in biology from Brown University in Providence, RI, a master’s degree in public health from the Yale University School of Medicine, and his medical degree from Brown University School of Medicine.

Humana Inc., headquartered in Louisville, Ky., is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at , including copies of:

Suggested Articles

States want to try value-based payment models for drug costs, but there are plenty of barriers to implementation, according to a new report.

Oncology centers blasted a Trump administration proposal to bundle Medicare payments for radiation therapy.

At least six states are creating their own health insurance marketplaces or seriously considering doing so.